Literature DB >> 2888696

Calculated pattern of intraportal insulin appearance without independent assessment of C-peptide kinetics.

A Vølund1, K S Polonsky, R N Bergman.   

Abstract

Prehepatic beta-cell insulin release can be calculated with C-peptide measurements, but this requires independent determination of kinetics of C-peptide disappearance from plasma. We introduce an approach by which a prehepatic insulin release pattern is calculated from plasma insulin and C-peptide, without separate C-peptide kinetic analysis. Human insulin and C-peptide were infused intraportally into conscious dogs (n = 11) at equimolar rates; endogenous insulin and C-peptide release were suppressed with somatostatin (0.8 micrograms . kg-1 . min-1). Insulin and C-peptide were infused at basal and equimolar rates (range 19-72 pmol/min in dogs), and the infusions were slowly increased, in stepwise fashion, to a maximum at 60 min (range 152-613 pmol/min) and subsequently renormalized at either 85 (n = 6) or 195 (n = 5) min. Plasma insulin and C-peptide measurements were described simultaneously by a composite model of insulin and C-peptide plasma kinetics, with the molar intraportal appearance rate due to the infusion R(t) as an unknown input for both insulin and C-peptide catabolism. The model assumes one-compartment disappearance kinetics for both peptides. Fitting the model to the measured insulin and C-peptide data, we were able to compute the insulin-appearance pattern accurately for every experiment; calculated and actual secretion rates were highly correlated (r = .93-.97) and had very similar temporal patterns. Also calculated were the fractional disappearance rates for human insulin (t1/2 = 6.9 min) and C-peptide (t1/2 = 14 min) in the dog, as well as the C-peptide distribution volume (12.3 +/- 0.5% body wt).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2888696     DOI: 10.2337/diab.36.10.1195

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  12 in total

1.  Quantitative and qualitative differences in basal and glucose- and arginine-stimulated insulin secretion in healthy subjects and different stages of NIDDM.

Authors:  K Ratheiser; W Reitgruber; M Komjati; P Bratusch-Marrain; H Vierhapper; W K Waldhäusl
Journal:  Acta Diabetol Lat       Date:  1990 Jul-Sep

2.  Population analysis of ethnicity and first-phase insulin release.

Authors:  Lanyi Xie; Robert P Hoffman; Peter Veng-Pedersen
Journal:  Diabetes Res Clin Pract       Date:  2010-05-31       Impact factor: 5.602

Review 3.  Menopausal Hormone Therapy and Type 2 Diabetes Prevention: Evidence, Mechanisms, and Clinical Implications.

Authors:  Franck Mauvais-Jarvis; JoAnn E Manson; John C Stevenson; Vivian A Fonseca
Journal:  Endocr Rev       Date:  2017-06-01       Impact factor: 19.871

Review 4.  Pharmacokinetic/pharmacodynamic modelling in diabetes mellitus.

Authors:  Cornelia B Landersdorfer; William J Jusko
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

5.  Loss of beta cell function as fasting glucose increases in the non-diabetic range.

Authors:  I F Godsland; J A R Jeffs; D G Johnston
Journal:  Diabetologia       Date:  2004-07-13       Impact factor: 10.122

6.  Role of islet amyloid polypeptide secretion in insulin-resistant humans.

Authors:  A Kautzky-Willer; K Thomaseth; G Pacini; M Clodi; B Ludvik; C Streli; W Waldhäusl; R Prager
Journal:  Diabetologia       Date:  1994-02       Impact factor: 10.122

7.  Insulin resistance syndrome in postmenopausal women with cardiological syndrome X.

Authors:  I F Godsland; D Crook; J C Stevenson; P Collins; G M Rosano; B Lees; M Sidhu; P A Poole-Wilson
Journal:  Br Heart J       Date:  1995-07

8.  Human insulin dynamics in women: a physiologically based model.

Authors:  Michael Weiss; Andrea Tura; Alexandra Kautzky-Willer; Giovanni Pacini; David Z D'Argenio
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-11-25       Impact factor: 3.619

9.  Insulin resistance--modelling studies.

Authors:  I F Godsland; C Walton; D Crook; V Wynn
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

10.  Glucose Homeostatic Law: Insulin Clearance Predicts the Progression of Glucose Intolerance in Humans.

Authors:  Kaoru Ohashi; Hisako Komada; Shinsuke Uda; Hiroyuki Kubota; Toshinao Iwaki; Hiroki Fukuzawa; Yasunori Komori; Masashi Fujii; Yu Toyoshima; Kazuhiko Sakaguchi; Wataru Ogawa; Shinya Kuroda
Journal:  PLoS One       Date:  2015-12-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.